美国细胞培养补充剂市场规模、份额和趋势分析报告：按产品类型、应用、最终用途和细分预测，2025-2033 年

美国细胞培养补充剂市场趋势：

预计 2024 年美国细胞培养补充剂市场规模将达到 8.133 亿美元，到 2033 年将达到 23.048 亿美元，2025 年至 2033 年的复合年增长率为 12.76%，这得益于生物製药需求的不断增长、细胞培养技术的进步疗法以及再生医学和细胞研究活动的持续增长疗法。

目录

第一章调查方法与范围

第二章执行摘要

第三章 细胞培养补充剂市场变数、趋势和范围

• 市场体系展望
  • 母市场展望
  • 相关/辅助市场前景。
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 美国细胞培养补充品市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析

第四章：美国细胞培养补充剂市场：产品类型估计与趋势分析

• 细分仪表板
• 美国细胞培养补充剂市场产品类型变化分析
• 美国细胞培养补充剂市场规模和趋势分析（按产品类型）（2021-2033）
• 血清补充剂
• 蛋白质类和重组类补充剂
• 化学定义的补充剂
• 其他的

第五章：美国细胞培养补充剂市场：应用评估和趋势分析

• 细分仪表板
• 美国细胞培养补充剂市场应用变化分析
• 美国细胞培养补充剂市场规模和趋势分析（按应用，2021-2033 年）
• 生物製药製造
• 细胞和基因治疗
• 药物研发
• 其他的

第六章美国细胞培养补充剂市场：最终用途估计和趋势分析

• 细分仪表板
• 美国细胞培养补充剂市场的最终用途变化分析
• 美国细胞培养补充剂市场规模和趋势分析（按最终用途，2021-2033 年）
• 细胞培养基製造商
• 製药和生物技术公司
• CDMO/CMO 和 CRO
• 学术研究机构

第七章 竞争态势

• 公司/竞争对手分类
• 战略地图
• 2024年企业市场分析
• 公司简介/上市公司
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • HiMedia Laboratories
  • Danaher
  • Sartorius AG
  • Corning Inc.
  • R&D Systems（Bio-Techne）
  • STEMCELL Technologies
  • Repligen Corporation
  • Proteintech Group, Inc

U.S. Cell Culture Supplements Market Trends:

The U.S. cell culture supplements market size was valued at USD 813.3 million in 2024 and is anticipated to reach USD 2304.8 million by 2033, growing at a CAGR of 12.76% from 2025 to 2033, driven by increasing demand for biopharmaceuticals, advancements in cell culture technologies, and expanding research activities in regenerative medicine and cell-based therapies.

U.S. Cell Culture Supplements Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. cell culture supplements market on the basis of product type, application, and end use:

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Serum-Based Supplements
  • Protein-Based & Recombinant Supplements
  • Chemically Defined Supplements
  • Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Manufacturing
  • Cell & Gene Therapy
  • Drug Discovery
  • Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell Culture Media Manufacturers
  • Pharmaceutical & Biotechnology Companies
  • CDMOs/ CMOs & CROs
  • Academic & Research Institutes

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Type Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use Segment
• 1.3. Information Analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Cell Culture Supplements Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growth of cell and gene therapy
    • 3.2.1.2. Rising biologics and biosimilars production
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of GMP-grade and specialty supplements
    • 3.2.2.2. Regulatory and standardization challenges
• 3.3. U.S. Cell Culture Supplements Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Cell Culture Supplements Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Cell Culture Supplements Market Product Type Movement Analysis
• 4.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
• 4.4. Serum-Based Supplements
  • 4.4.1. Serum-Based Supplements Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 4.5. Protein-Based & Recombinant Supplements
  • 4.5.1. Protein-Based & Recombinant Supplements Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 4.6. Chemically Defined Supplements
  • 4.6.1. Kits & Reagents Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Cell Culture Supplements Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Cell Culture Supplements Market Application Movement Analysis
• 5.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Biopharmaceutical Manufacturing
  • 5.4.1. Biopharmaceuticals Manufacturing Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 5.5. Cell & Gene Therapy
  • 5.5.1. Cell & Gene Therapy Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 5.6. Drug Discovery
  • 5.6.1. Drug Discovery Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Cell Culture Supplements Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Cell Culture Supplements Market End Use Movement Analysis
• 6.3. U.S. Cell Culture Supplements Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Cell Culture Media Manufacturers
  • 6.4.1. Cell Culture Media Manufacturers Companies Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.5. Pharmaceutical & Biotechnology Companies
  • 6.5.1. Pharmaceuticals & Biotechnology Companies Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.6. CDMOs/ CMOs & CROs
  • 6.6.1. CDMOs/ CMOs & CROs Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 6.7. Academic & Research Institutes
  • 6.7.1. Academic & Research Institutes Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Merck KGaA
    • 7.4.1.1. Company Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product/Service Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Thermo Fisher Scientific Inc.
    • 7.4.2.1. Company Overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product/Service Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. HiMedia Laboratories
    • 7.4.3.1. Company Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product/Service Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Danaher
    • 7.4.4.1. Company Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product/Service Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Sartorius AG
    • 7.4.5.1. Company Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product/Service Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Corning Inc.
    • 7.4.6.1. Company Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product/Service Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. R&D Systems (Bio-Techne)
    • 7.4.7.1. Company Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product/Service Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. STEMCELL Technologies
    • 7.4.8.1. Company Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product/Service Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Repligen Corporation
    • 7.4.9.1. Company Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product/Service Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Proteintech Group, Inc
    • 7.4.10.1. Company Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product/Service Benchmarking
    • 7.4.10.4. Strategic Initiatives

List of Tables

• Table 1 List of abbreviation
• Table 2 U.S. cell culture supplements market, by product type, 2021 - 2033 (USD Million)
• Table 3 U.S. cell culture supplements market, by application, 2021 - 2033 (USD Million)
• Table 4 U.S. cell culture supplements market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 U.S. cell culture supplements market: Market outlook
• Fig. 5 U.S. cell culture supplements market: Segment outlook
• Fig. 6 U.S. cell culture supplements market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 U.S. cell culture supplements market driver impact
• Fig. 9 U.S. cell culture supplements market restraint impact
• Fig. 10 U.S. cell culture supplements market: Product type outlook and key takeaways
• Fig. 11 U.S. cell culture supplements market: Product type movement analysis
• Fig. 12 Serum-Based supplements market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 13 Protein-based & recombinant supplements market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 14 Chemically defined supplements market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 15 Others market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 16 U.S. cell culture supplements market: Application outlook and key takeaways
• Fig. 17 U.S. cell culture supplements market: Application movement analysis
• Fig. 18 Biopharmaceutical manufacturing market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 19 Cell & gene therapy market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 20 Drug discovery market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 21 Others market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 22 U.S. cell culture supplements market: End user outlook and key takeaways
• Fig. 23 U.S. cell culture supplements market: End user movement analysis
• Fig. 24 Cell culture media manufacturers market estimates and forecasts,2021 - 2033 (USD Million)
• Fig. 25 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 CDMOs/ CMOs & CROs market estimates and forecasts,2021 - 2033 (USD Million)
• Fig. 27 Academic & research institutes market estimates and forecasts,2021 - 2033 (USD Million)